Company

Companies of New York

Keros Therapeutics

Keros Therapeutics

Healthcare

Connections 1

Subscribe To favorites

Description

Keros Therapeutics is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need.

Its protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes (MDS) and myelofibrosis. Its lead small molecule product candidate, KER-047, is being developed for the treatment of anemia resulting from iron imbalance.

Its third product candidate, KER-012, is being developed for the treatment of pulmonary arterial hypertension (PAH), and for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta. Its KER-050 is an engineered ligand trap comprised of a modified ligand-binding domain of the transforming growth factor-beta (TGF-B) receptor.

Website

https://www.kerostx.com

Rating GlobalNY.biz

Mentions in the news View all

Quotes

All

NASA Names Astronaut Christina Koch Acting Deputy Chief Engineer

ISAACMAN Jared
ISAACMAN Jared

Christina has seen NASA engineering from both sides of the equation: developing complex systems on the ground and trusting them with her life in space

Blondie Reopens Its New York Story With High Noon

HARRY Deborah
HARRY Deborah

This music feels grounded in the present, shaped by who we are and how we’re living now

Pedro Pascal Discovers His Most Intimidating Co-Star Is a Cello

PASCAL Pedro
PASCAL Pedro

I’d never been so afraid

Paul Bettany Reveals the Call That Rebuilt His Hollywood Career

BETTANY Paul
BETTANY Paul

Maybe my career is over

Matthew Lillard Says Cult Fame Still Has Not Won Hollywood’s Trust

LILLARD Matthew
LILLARD Matthew

Nobody ever equates me with greatness